These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 25424804

  • 21. Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice.
    Tang LH, Lim JH, Kuah LF, Lau YF.
    Vaccine; 2014 Sep 22; 32(42):5375-8. PubMed ID: 25130540
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Chung KY, Coyle EM, Jani D, King LR, Bhardwaj R, Fries L, Smith G, Glenn G, Golding H, Khurana S.
    Vaccine; 2015 Jul 31; 33(32):3953-62. PubMed ID: 26093202
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
    Wang Y, Zhang Y, Wu J, Lin Y, Wu Z, Wei Y, Wei X, Qin J, Xue C, Liu GD, Cao Y.
    Virus Res; 2017 Oct 15; 242():16-23. PubMed ID: 28912070
    [Abstract] [Full Text] [Related]

  • 31. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
    Rajesh Kumar S, Syed Khader SM, Kiener TK, Szyporta M, Kwang J.
    PLoS One; 2013 Oct 15; 8(6):e63856. PubMed ID: 23762234
    [Abstract] [Full Text] [Related]

  • 32. Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines.
    He B, Xia S, Yu F, Fu Y, Li W, Wang Q, Lu L, Jiang S.
    J Gen Virol; 2016 Feb 15; 97(2):327-333. PubMed ID: 26653217
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine.
    Gou X, Wu X, Shi Y, Zhang K, Huang J.
    Hum Vaccin Immunother; 2020 Feb 15; 16(2):286-294. PubMed ID: 31419167
    [Abstract] [Full Text] [Related]

  • 40. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF, Glenn GM.
    Vaccine; 2013 Sep 13; 31(40):4305-13. PubMed ID: 23891795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.